< Back to previous page
Researcher
Chantal Mathieu
- Disciplines:Other clinical sciences not elsewhere classified
Affiliations
- Clinical and Experimental Endocrinology (Division)
Member
From1 Oct 1999 → Today
Infrastructure
1 - 1 of 1
Projects
1 - 10 of 90
- MAPS-T1D: Multi-omics Analysis of the Pancreas, Spatially resolved, in childhood and adult-onset Type 1 DiabetesFrom1 Oct 2025 → TodayFunding: BOF - postdoctoral mandates
- Investigating natural history and therapeutic strategies across different stages of type 1 diabetes using innovative technologies.From13 Sep 2025 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- How Can Multiphase Optimization Strategy (MOST), enriched by perspectives of social determinants of health and lived experience with T1D, optimally inform design and implementation of early detection of T1D? – The case of EDENT1FI general population earlyFrom12 Jun 2025 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Continued provision of an affordable medium-parametric cell analysis solution at the KU Leuven Flow Cytometry core facilityFrom1 Jan 2025 → 31 Dec 2025Funding: Own budget, for example: patrimony, inscription fees, gifts
- Age-related heterogeneity in response to disease-modifying therapies in new-onset type 1 diabetesFrom1 Jan 2025 → TodayFunding: FWO research project (including WEAVE projects)
- Continued provision of an affordable medium-parametric cell analysis solution at the KU Leuven Flow Cytometry core facilityFrom1 Jan 2025 → 31 Dec 2025Funding: BOF - scientific equipment program
- Personalized precision medicine for the prevention and reversal of type 1 diabetes: a stepwise approachFrom1 Oct 2024 → TodayFunding: BOF - various, BOF - projects
- Neutrophils and their role in type 1 diabetesFrom10 Sep 2024 → 1 Sep 2025Funding: Own budget, for example: patrimony, inscription fees, gifts
- New technologies for the management of (gestational) diabetes in pregnancyFrom1 Aug 2024 → TodayFunding: FWO Strategic Basic Research Grant
- Accelerate and promote type 1 diabetes (T1D) research to better understand disease pathogenesis and support development of new therapiesFrom1 Apr 2024 → 31 Mar 2025Funding: Foreign private sponsor - undefined
Publications
1 - 10 of 727
- Exploring the psychosocial implications of general population screening for paediatric type 1 diabetes in Europe: Protocol for a mixed-methods study(2026)Published in: Diabetic MedicineISSN: 0742-3071Issue: 6Volume: 43
- An international consensus on screening and monitoring early-stage type 1 diabetes: A roadmap to European implementation(2026)Published in: Diabetes, Obesity & MetabolismISSN: 1462-8902Issue: 5Volume: 28
- Hypoglycaemia in a patient with undiagnosed Doege-Potter syndrome: A case report and narrative literature review.(2026)Published in: European journal of anaesthesiology and intensive careISSN: 2767-7206Issue: 2Volume: 5Pages: e0099
- The Use of Automated Insulin Delivery around Physical Activity and Exercise in Type 1 Diabetes: A Position Statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPAD)(2026)Published in: HORMONE RESEARCH IN PAEDIATRICSISSN: 1663-2818Issue: 3Volume: 99Pages: 391 - 418
- Impact of Metabolic Bariatric Surgery on Weight Loss and Glycemic Control in Adults With Type 1 Diabetes: A Multicenter Retrospective Cohort Study(2026)Published in: Diabetes CareISSN: 0149-5992Issue: 4Volume: 49Pages: 658 - 663
- Mineralocorticoid receptor antagonists: Efficacy and safety in chronic kidney disease(2026)Published in: Diabetes, Obesity & MetabolismISSN: 1462-8902
- Finerenone in Type 1 Diabetes and Chronic Kidney Disease(2026)Published in: New England Journal of MedicineISSN: 0028-4793Issue: 10Volume: 394
- Country-level implementation of Europe's Safe Hearts Plan for cardiovascular health.(2026)Published in: The Lancet Diabetes & EndocrinologyISSN: 2213-8587Issue: 3Volume: 14Pages: 199 - 201
- Who Benefits Most from Advanced Hybrid Closed Loop Therapy in Pregnancy Across Different Subgroups: A Secondary Analysis of the Randomized Controlled CRISTAL Trial(2026)Published in: Diabetes Technology & TherapeuticsISSN: 1520-9156Issue: 3Volume: 28Pages: 253 - 263
- Diabetes community calls for quality standards for continuous glucose monitoring devices(2026)Published in: Lancet Reg Health EurISSN: 2666-7762Volume: 62
Patents
1 - 8 of 8
- Biomarkers for diabetes therapy
- Methods And Compositions For Treating Type 1 Diabetes Comprising Teplizumab And Verapamil
- BIOMARKERS FOR DIABETES THERAPY
- Biomarkers for diabetes therapy
- Improved methods for pancreatic islet transplantation
- Citrullinated peptides for diagnosis or treatment of diabetes
- Improved methods for pancreatic islet transplantation
- RESISTANCE TO OXIDATIVE STRESS